UBS Group Downgrades Sandoz Group (OTCMKTS:SDZNY) to Hold

Sandoz Group (OTCMKTS:SDZNY) was downgraded by analysts at UBS Group from a “strong-buy” rating to a “hold” rating in a research report issued on Monday,Zacks.com reports.

Separately, BNP Paribas downgraded shares of Sandoz Group from a “strong-buy” rating to a “hold” rating in a report on Monday, December 2nd.

Sandoz Group Stock Performance

Shares of SDZNY stock opened at $48.61 on Monday. The stock’s fifty day moving average price is $43.52 and its 200 day moving average price is $43.20. Sandoz Group has a 1-year low of $27.79 and a 1-year high of $48.66.

About Sandoz Group

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.